Genetic testing company 23andMe has filed for Chapter 11 bankruptcy protection and is seeking a buyer as part of its restructuring efforts, following significant financial and operational challenges. CEO and co-founder Anne Wojcicki has resigned, with Joe Selsavage stepping in as interim CEO, as the company hopes the court-supervised process will help reduce costs and resolve liabilities. This development follows a workforce reduction and board resignation, marking a pivotal moment for the once-leading company in the genetic testing industry.
